See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2023_Mersana_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 319,219,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,985,000 |
| 3 | remainder_Assets | 11,136,000 |
| 4 | LiabilitiesCurrent | 91,533,000 |
| 5 | LiabilitiesNoncurrent | 150,750,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 157,206,737 |
| 9 | ResearchAndDevelopmentExpense | 228,160,271 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 16,943,817 |
| 12 | remainder_NetIncome | -301,827 |
| 13 | remainder_ComprehensiveNetIncome | -90,280 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 334,340,000 |
| 1 | Liabilities | 242,283,000 |
| 2 | Expenses | 385,367,008 |
| 3 | Revenues | 16,943,817 |
| 4 | StockholdersEquity | 92,057,000 |
| 5 | NetIncome | -368,725,018 |
| 6 | ComprehensiveNetIncome | -368,770,158 |
| 7 | BaseVar | 489,662,966 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.583 |
| 9 | EconomicCapitalRatio | 1.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
